肿瘤学中PET/CT使用的良好临床实践推荐
本文是法国核医学学会与法国综合癌症中心联合会等合作制定的肿瘤学PET/CT良好临床实践推荐,基于2003年版推荐更新,经法国国家卫生管理局与法国癌症研究所联合认证,并用于EANM转诊指南。
要点
- 该推荐由法国核医学学会与法国综合癌症中心联合会等合作制定,经法国国家卫生管理局与法国癌症研究所联合认证。
- 推荐基于全面文献复习与专家小组严格评估,涵盖肿瘤学PET/CT适应证及新获批示踪剂。
- 推荐采用标准-选项-推荐方法学制定,并用于EANM转诊指南。
核心结论
- 本文旨在更新2003年版肿瘤学PET/CT推荐,形成经法国国家卫生管理局与法国癌症研究所联合认证的良好临床实践推荐。
研究设计与样本
- 由法国核医学学会与法国综合癌症中心联合会合作成立焦点小组,采用标准-选项-推荐方法学制定推荐。
- 推荐基于全面文献复习与专家小组严格评估,专家包括器官专科医师、临床肿瘤医师、外科医师和影像专科医师。
临床应用与阅片要点
- 该推荐经法国国家卫生管理局与法国癌症研究所联合认证,并获得方法学批准标签。
- 这些数据也被用于EANM转诊指南。
局限性
- 2003年版推荐发布后已有大量科学论文发表及新示踪剂获批上市,故需更新。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Positron emission tomography/computed tomography (PET/CT) is a nuclear medicine functional imaging technique with proven clinical value in oncology. PET/CT indications are continually evolving with fresh advances made through research. French practice on the use of PET in oncology was framed in recommendations based on Standards-Options-Recommendations methodology and coordinated by the French federation of Comprehensive Cancer Centres (FNLCC). The recommendations were originally issued in 2002 followed by an update in 2003, but since then, a huge number of scientific papers have been published and new tracers have been licenced for market release. The aim of this work is to bring the 2003 version recommendations up to date. For this purpose, a focus group was set up in collaboration with the French Society for Nuclear Medicine (SFMN) to work on developing good clinical practice recommendations. These good clinical practice recommendations have been awarded joint French National Heath Authority (HAS) and French Cancer Institute (INCa) label status-the stamp of methodological approval. The present document is the outcome of comprehensive literature review and rigorous appraisal by a panel of experts, organ specialists, clinical oncologists, surgeons and imaging specialists. These data were also used for the EANM referral guidelines.
引用
- Salaün PY, Abgral R, Malard O, et al. Good clinical practice recommendations for the use of PET/CT in oncology. Eur J Nucl Med Mol Imaging. 2019. PMID: 31637482. doi:10.1007/s00259-019-04553-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。